Greenwich LifeSciences, Inc.
GLSI
$22.23
$0.582.68%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -23.02% | -8.21% | -96.16% | -86.96% | -91.40% |
| Total Depreciation and Amortization | -75.00% | -50.00% | -25.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -17.06% | -6.20% | 324.83% | 284.89% | 244.95% |
| Change in Net Operating Assets | 0.49% | -26.45% | 247.00% | 37.39% | 1,303.12% |
| Cash from Operations | -74.65% | -36.43% | -13.51% | -25.33% | -9.16% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 350.14% | 174.65% | 54.82% | 43.64% | 1,425.34% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 350.14% | 174.65% | 54.82% | 43.64% | 1,425.34% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 381.40% | 172.00% | 39.32% | -10.23% | 56.97% |